参考文献
1. Rodriguez-Garcia R, Lopez-Montero I, Mell M, et al. Direct Cytoskeleton Forces Cause Membrane Softening in Red Blood Cells. Biophys J. 2016; 111(5):1101.
2. Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018; 4:18010.
3. Roumenina LT, Rayes J, Lacroix-Desmazes S, et al. Heme: Modulator of Plasma Systems in Hemolytic Diseases. Trends Mol Med. 2016; 22(3):200-213.
4. Weisel JW, Litvinov RI. Red blood cells: the forgotten player in hemostasis and thrombosis. J Thromb Haemost. 2019; 17(2):271-282.
5. Wendelboe AM, Raskob GE. Global Burden of Thrombosis: Epidemiologic Aspects. Circ Res. 2016; 118(9):1340-7.
6. Diaz JA, Saha P, Cooley B, et al. Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application. J Thromb Haemost. 2019; 17(4):699-707.
7. Grover SP, Mackman N. Intrinsic Pathway of Coagulation and Thrombosis. Arterioscler Thromb Vasc Biol. 2019; 39(3):331-338.
8. Zhu XY, Liu HC, Guo SY, et al. A Zebrafish Thrombosis Model for Assessing Antithrombotic Drugs. Zebrafish. 2016; 13(4):335-44.
9. Clapier CR, Iwasa J, Cairns BR, et al. Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes. Nat Rev Mol Cell Biol. 2017; 18(7):407-422.
10. Itoh K, Wakabayashi N, Katoh Y, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999; 13(1):76-86.
11. Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997; 236(2):313-22.
12. Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019; 35(6):830-849.
转载须知
【非原创文章】本文著作权归文章作者所有,欢迎个人转发分享,未经允许禁止转载,作者拥有所有法定权利,违者必究。